Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone. (Q38876257)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

review article

1 reference

title

Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

1 reference

Dinara Jaqueline Moura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

João Antonio Pêgas Henriques

15 March 2020

object named as

João Antonio Pêgas Henriques

5

1 reference

15 March 2020

Roberto Marques Damiani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Cassiana Macagnan Viau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Rafael Andrade Caceres

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Jenifer Saffi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

publication date

25 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

published in

Archives of Toxicology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

page(s)

2063-2076

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342245%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00204-016-1759-y

15 March 2020

exact match

0 references

cites work

The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Poly (ADP-ribose) polymerase as a novel therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Poly(ADP-ribose): a signaling molecule in different paradigms of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Novel HeLa topoisomerase II is the II beta isoform: complete coding sequence and homology with other type II topoisomerases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Poly(ADP-ribose): PARadigms and PARadoxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Molecular recognition models: a challenge to overcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

DNA topoisomerase-trapping antitumour drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Application of Fenton, photo-Fenton, solar photo-Fenton, and UV/H2O2 to degradation of the antineoplastic agent mitoxantrone and toxicological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

DNA topoisomerases: structure, function, and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The expanding role of PARPs in the establishment and maintenance of heterochromatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Molecular mechanisms of superoxide production by the mitochondrial respiratory chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The role of reductive and oxidative metabolism in the toxicity of mitoxantrone, adriamycin and menadione in human liver derived Hep G2 hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Induction and escalation therapies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The expanding role of poly(ADP-ribose) metabolism: current challenges and new perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Hydroxyl radical generation during mitochondrial electron transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The expanding field of poly(ADP-ribosyl)ation reactions. 'Protein Modifications: Beyond the Usual Suspects' Review Series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The wanderings of a free radical

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Oxygen toxicity, oxygen radicals, transition metals and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIβ downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Drug-induced conformational population shifts in topoisomerase-DNA ternary complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Recent advances in the prevention of anthracycline cardiotoxicity in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Subclinical myocardial dysfunction in multiple sclerosis patients remotely treated with mitoxantrone: evidence of persistent diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Role of mtDNA lesions in anthracycline cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Unraveling the biological roles of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Cell death in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

DNA-PK is activated by nucleosomes and phosphorylates H2AX within the nucleosomes in an acetylation-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Drugging topoisomerases: lessons and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

DNA topoisomerases and their poisoning by anticancer and antibacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Mammalian Base Excision Repair: Functional Partnership between PARP-1 and APE1 in AP-Site Repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Role of poly(ADP-ribose) formation in DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Cardiovascular effects of systemic cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Oxidative stress: oxidants and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Proteomic insights into chronic anthracycline cardiotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Oxidative stress and mitochondrial DNA damage in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Topoisomerase 2β: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Doxorubicin-induced cardiac mitochondrionopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Effects of 3-aminobenzamide on ventricular function in infarct heart assessed by quantitative tissue velocity imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Cardiomyocyte death in doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y

‘Daunomycin’, a New Antibiotic of the Rhodomycin Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-016-1759-Y